Browse Categories

Publications by authors named "Bryn Nelson"

  • Page 1 of 7
Counseling gap may worsen endometrial cancer disparities in Black women: A study finds that women of Black or African ancestry have fewer cancer-associated genetic mutations than White women but less access to genetic counseling.
Bryn Nelson William Faquin

Cancer Cytopathol

January 2025

View Article and Find Full Text PDF
The deadliness of loneliness: Studies suggest that those who are lonely, isolated, or living alone may face a higher risk of cancer and cancer mortality-adding to the growing alarm and hunt for solutions.
Bryn Nelson William Faquin

Cancer Cytopathol

December 2024

View Article and Find Full Text PDF
Retrieving new clues about a dog breed's "insane" cancer risk: In this second of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, research digging into remarkably high cancer mortality rates for golden retrievers has revealed some intriguing new insights.
Bryn Nelson William Faquin

Cancer Cytopathol

September 2024

View Article and Find Full Text PDF
Cancer-aiding elements begin illuminating the genome's "dark matter": Within what was once deemed useless junk, virus-like retrotransposons, long noncoding RNAs, and other exotic molecules have emerged as beacons for cancer researchers.
Bryn Nelson William Faquin

Cancer Cytopathol

November 2024

View Article and Find Full Text PDF
Researchers confront a rising tide of cancer misinformation: A fledgling field of research has documented major harms from misinformation on cancer treatment and prevention and is weighing how physicians can best counter the bad advice.
Bryn Nelson William Faquin

Cancer Cytopathol

October 2024

View Article and Find Full Text PDF
Exposing the naked truth about how mole-rats evade cancer: In this first of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, researchers are exploring how adaptations to their extreme environment may have given naked mole-rats potent cancer-fighting tools.
Bryn Nelson William Faquin

Cancer Cytopathol

August 2024

View Article and Find Full Text PDF
The power and pitfalls of using social media to study rare cancers: Facebook, X, and other platforms can aid patient education and recruitment efforts, though experts caution that studies can be methodologically limited and unrepresentative.
Bryn Nelson William Faquin

Cancer Cytopathol

July 2024

View Article and Find Full Text PDF
Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeed.
Bryn Nelson William Faquin

Cancer Cytopathol

June 2024

View Article and Find Full Text PDF
Climate change is threatening access to cancer care: In this second of a two-part series on cancer and climate change, natural disasters fueled by global warming are creating new obstacles to cancer care for vulnerable communities.
Bryn Nelson William Faquin

Cancer Cytopathol

May 2024

View Article and Find Full Text PDF
Growing cancer risks on a warming planet: In this first of a two-part series on cancer and climate change, recent natural disasters highlight how global warming is increasing cancer risks and widening health disparities.
Bryn Nelson William Faquin

Cancer Cytopathol

April 2024

View Article and Find Full Text PDF
Growing threats of a mass exodus in governmental public health: Recruitment and retention woes, a lack of sustained investment, and partisan harassment and attacks are creating a mounting crisis for public health efforts, including cancer prevention.
Bryn Nelson William Faquin

Cancer Cytopathol

March 2024

View Article and Find Full Text PDF
Heightened but variable COVID-19 risks for patients with cancer: Multiple studies have underscored certain cancer-associated dangers while reaffirming the protective effects of vaccination and other prevention strategies.
Bryn Nelson William Faquin

Cancer Cytopathol

February 2024

View Article and Find Full Text PDF
Generic cancer drugs are still in short supply: The ongoing shortage has forced hospitals to continue rationing drugs and prompted new calls for federal investment and long-term solutions.
Bryn Nelson William Faquin

Cancer Cytopathol

January 2024

View Article and Find Full Text PDF
An uncertain balance: In search of the sweet spot for cancer screening: In this second of a two-part series on the struggle to balance preventive care costs and benefits, the lessons of thyroid cancer overdiagnosis and overtreatment highlight the difficulties surrounding evidence-based decisions.
Bryn Nelson William Faquin

Cancer Cytopathol

December 2023

View Article and Find Full Text PDF
The unexpected costs of "free" preventive care: In this first of a two-part series on the struggle to balance preventive care costs and benefits, federal laws have directed insurers to offer free cancer screens, but loopholes and uneven implementation have left many consumers holding the bag.
Bryn Nelson William Faquin

Cancer Cytopathol

November 2023

View Article and Find Full Text PDF
Understanding the "zombie cells" that won't die: Cell senescence is emerging as a highly complicated but newly energized front in the battle against cancer.
Bryn Nelson William Faquin

Cancer Cytopathol

October 2023

View Article and Find Full Text PDF
New chances and challenges for preventing HPV associated throat cancer: Otolaryngologists sense an opening for increasing vaccination rates and decreasing the incidence of HPV-associated oropharyngeal cancer.
Bryn Nelson William Faquin

Cancer Cytopathol

September 2023

View Article and Find Full Text PDF
Artificial intelligence and medicine: Mounting risks amid the promise: In this second of a two-part series, developers have touted artificial intelligence as a boon for both medical research and clinical applications, but plenty of pitfalls are giving ethicists and other experts considerable pause.
Bryn Nelson William Faquin

Cancer Cytopathol

July 2023

View Article and Find Full Text PDF
Artificial intelligence and cytopathology: Where are we heading?: In this first of a two-part series, a recent burst of research in artificial intelligence is showing how the algorithms can expand beyond gynecologic applications-and how they might shift responsibilities for the cytology workforce: In this first of a two-part series, a recent burst of research in artificial intelligence is showing how the algorithms can expand beyond gynecologic applications-and how they might shift responsibilities for the cytology workforce.
Bryn Nelson William Faquin

Cancer Cytopathol

June 2023

View Article and Find Full Text PDF
Breaking free of the research silo: A growing case for multidisciplinary work: From studying human origins to developing cancer diagnoses and treatments, working across disciplines is not always easy, but it is often transformative: From studying human origins to developing cancer diagnoses and treatments, working across disciplines is not always easy, but it is often transformative.
Bryn Nelson William Faquin

Cancer Cytopathol

May 2023

View Article and Find Full Text PDF
Weaponization of Disgust: Vilifying a person or group of people is linked to increased violence against them.
Bryn Nelson

Sci Am

May 2023

View Article and Find Full Text PDF
The "preexisting condition" invention in American health care: A lingering threat to preventive care: This second of a two-part series reveals how new research has detailed how expanded access to health insurance is aiding preventive care, and how further gains could be thwarted by unresolved insurance provisions: This second of a two-part series reveals how new research has detailed how expanded access to health insurance is aiding preventive care, and how further gains could be thwarted by unresolved insurance provisions.
Bryn Nelson William Faquin

Cancer Cytopathol

April 2023

View Article and Find Full Text PDF
The "preexisting condition" invention in American health care: The persistence of a potential insurance nightmare: In this first part of a two-part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goals: In this first part of a two-part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goals.
Bryn Nelson William Faquin

Cancer Cytopathol

March 2023

View Article and Find Full Text PDF
Generalists and specialists: Two sides of the same coin for cancer care?: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tap: Amid growing concern over a decline in generalists, experts are urging new incentives to extend their reach and are paying more attention to key generalist tools that even specialists can tap.
Bryn Nelson William Faquin

Cancer Cytopathol

February 2023

View Article and Find Full Text PDF
Privacy Policy Site Map

© LitMetric 2025. All rights reserved.